News
Topics
Dr. Kai from Safety BU to Deliver an Oral Presentation at the 9th Drug Discovery & Lead Optimization Conference
Dr. Kiyonori Kai from the Safety Business Unit, will deliver an oral presentation at The 9th Drug...
Researcher Tanaka and Ogawa from Pharmacology BU to Present at a symposium hosted by CIEM
Our researcher, Hiroshi Tanaka and Masahiro Ogawa from the Pharmacology Business Unit, will give an oral presentation...
Researcher Tabata from Pharmacology BU to Present a Poster at the 84th Annual Meeting of the Japanese Cancer Association
Our researcher, Ryotaro Tabata from the Pharmacology Business Unit, will present a poster at the 84th Annual...
Researcher Unno from Pharmacology BU to Present a Poster at the 84th Annual Meeting of the Japanese Cancer Association
Our researcher, Satoko Unno from the Pharmacology Business Unit, will present a poster at the 84th Annual...
PRD Therapeutics Initiates First-in-Human Clinical Trial of SOAT2-Selective Inhibitor ‘PRD001’ — Axcelead DDP Provides Comprehensive Non-Clinical Development Support —
PRD Therapeutics, Inc. (“PRD Therapeutics”), a clinical stage company focused on developing novel lipid metabolism regulators targeting homozygous...